|
⚲
|
| Keyboard |
| Cannon Gillian
✚
|
|
|---|---|
| CIK # | 0001833910 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001833910] | |
| 4 | [0001833910] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cannon Gillian | |
| Xenon Pharmaceuticals Inc | |
| Corcept Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Corcept Therapeutics Inc CORT
Stock option (right to buy) · derivative
|
2025-06-10 | Grant | 15,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Share Option (Right to Buy) · derivative
|
2025-06-05 | Grant | 17,012 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Restricted Share Units · derivative
|
2025-06-05 | Grant | 2,645 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2024-06-05 | Grant | 15,542 | $0.00 | |
|
Corcept Therapeutics Inc CORT
Stock option (right to buy) · derivative
|
2024-05-17 | Grant | 30,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2023-08-10 | Grant | 28,000 | $0.00 | |
|
Corcept Therapeutics Inc CORT
Stock option (right to buy) · derivative
|
2023-05-19 | Grant | 30,000 | $0.00 | |
|
Corcept Therapeutics Inc CORT
Stock option (right to buy) · derivative
|
2022-05-31 | Grant | 20,000 | $0.00 | |
|
Corcept Therapeutics Inc CORT
Stock Option (Right to Buy) · derivative
|
2021-05-26 | Grant | 20,000 | $0.00 | |
|
Corcept Therapeutics Inc CORT
Stock Option (Right to Buy) · derivative
|
2020-12-01 | Grant | 60,000 | $0.00 |